Dr. J.P.P. Meijerink

Update Persondata

• cancer
• cell
• expression
• gene
• genes
• mutations
• patients
• receptor
• resistance
• risk

Active as

Publications

(the most recent at the top)

In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia

PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia

The TLX1 oncogene drives aneuploidy in T cell transformation

PHF6 mutations in T-cell acute lymphoblastic leukemia

NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL

All publications..

Enhanced publications

(the most recent at the top)

Doctoral Thesis: Molecular-genetic insights in pediatric T-cell acute lymphoblastic leukemia

Current research

(the most recent research is at the top)
Project leader	Discovering new oncogenic aberrations in T-cell acute lymphoblastic leukemia
Project leader	Identification of new cancer genes involved in lymphomagenesis
Project leader	Molecular determinants of therapy response and outcome in childhood cancer

Completed research projects

(the most recent research is at the top)
Project leader	Characterization of a novel BCRABL-like subtype with high relapse-risk in pediatric acute lymphoblastic leukemia
Project leader	Molecular-genetic Insights in Pediatric T-cell Acute Lymphoblastic Leukemia
Co-supervisor	Identification of Prognose Genetic Factors in Pediatric T-cell Acute Lymphoblastic Leukemia
Project leader	Polymorphism in the glucocorticoid receptor genes and abnormal receptors as determinants of resistance to glucocorticoid induced apoptosis
Project leader	Prognostic relevance of molecular-genetic markers in pediatric T-cell acute lymphoblastic leukemia and identification of drugable targets

All completed research..

Classification

D23362	Pediatrics